Western blot and ChIP experiments provided confirmation of p53-driven regulation of E2F7.<h4>Results</h4>Elevated levels of E2F7 were detected in GBM tissue and were correlated with a poor prognosis for patients. The gene discussed is E2F7; the disease is glioblastoma.